Orion Pharma

In pharma industry, most clinical trials are delayed due to patient recruitment

Healthcare

Value Creation Model™ helped Orion Pharma to identify improvement points in the partner ecosystem

Within the pharma industry, clinical trials are globally delayed due to patient recruitment. With very high track record, recruitment being one very critical part of drug development. This causes budget exceeding to the pharmaceutical companies, but more importantly, the delays can be harmful to the patients waiting for the new drug.

How to improve the predictability of clinical trials?

Each clinical trial includes several vendors and collaborators, and the budget varies between 10–20 million euros. Therefore Orion Pharma wanted to increase the predictability of its clinical trials. Clinical trials are conducted with an operative network of collaborators and their management can be demanding. Furthermore Orion Pharma recognized that it had not managed this ecosystem as actively as it should to receive proactively information about possible delays. Orion Pharma finds it very important to hear from different collaborators as early as possible if the trial was heading to the wrong direction, what kind of risks were involved, and to consider the corrective measures they should take. Overall, the network management and communication was rather reactive when it should have been more proactive.

Visualizing the pharma industry ecosystem with Value Creation Model

Qentinel’s Value Creation Model™ helped Orion Pharma to describe and visualize the entire pharma industry ecosystem and identify the inter-dependencies. The Value Creation Model helped Orion Pharma to identify intervention points in which we can proactively take concrete actions to steer the trial into the right direction. Furthermore, the model also visualized the big picture and the different types of connections in it, which we had not realized before. It enables mutually beneficial discussions between the different parties in the ecosystem.

Orion has used the Value Creation Model as a part of larger Lean-project.  Consequently the model allows development of the metrix, which they had longed for to complement their recently launched Lean-project. Model offers an opportunity to think about real-time measuring.

Orion Pharma sees Qentinel as a pioneer with the Value Creation Model.

EmailLinkedInTwitterFacebook
Benefits for Orion Pharma

01

Improving predictability of clinical trials

More effectiveness managing clinical trials in the collaborator network. Changing collaborator management and communication from reactive to proactive.

02

Connecting the ecosystem

Visualizing the big picture for different types of connections, enabling mutually beneficial discussions among different parties in the ecosystem.

03

Real-time measurement

Preventing program delays by measuring results in-process.

About Orion Pharma

Orion is a globally operating Finnish pharmaceutical company–a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion’s pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory for which Orion develops inhaled Easyhaler® pulmonary drugs. Orion’s net sales in 2016 amounted to EUR 1,074 million and the company had about 3,500 employees. Orion’s A and B shares are listed on Nasdaq Helsinki. Founded in 1917, Orion celebrated its centennial anniversary in 2017.

Learn more

“The Value Creation Model™ has helped us to identify intervention points in which we can proactively take concrete actions to steer the trial into the right direction. The model also visualised the big picture to us and the different types of connections in it, which we had not realised before. It enables mutually beneficial discussions between the different parties in the ecosystem.“

– Taru Blom, Vice President, Development at Orion Pharma R&D

Want to learn how we can boost productivity with automated software testing?

Esko Hannula

Chief Executive Officer
+1 312 731 9215

Tieto

Personalizing customer experience

Qentinel helped Tieto to concretize how employees can impact on customer experience. Tieto aims to be its customers’ first choice for business renewal. Customer experience is considered business-critical… Read more

Kalmar

Exact information for decision-making

Test automation offers exact information for decision-making Kalmar is the pioneer within its field of terminal automation and energy-efficient container handling. With the assistance of Qentinel, Kalmar has… Read more

Sanoma Media

Quality assurance of new ERP system

Sanoma Media operates on more channels than any other Finnish media house. They are a pioneer in digital publishing so finally the day came when it was the… Read more

Contact us